Looking in the Mirror Is the Shortest Way to Improvement

Abstract

We would like to thank Dr Kareem Bedeir for the Letter to the Editor 1 Bedeir K. Shooting ourselves in the foot. Ann Thorac Surg. Ann Thorac Surg. 2022; 114: 2394-2395 Abstract Full Text Full Text PDF Scopus (1) Google Scholar regarding our article 2 Lam K.Y. Reardon M.J. Yakubov S.J. et al. Surgical sutureless and sutured aortic valve replacement in low-risk patients. Ann Thorac Surg. 2022; 113: 616-622 Abstract Full Text Full Text PDF PubMed Scopus (5) Google Scholar in The Annals of Thoracic Surgery on surgical sutureless aortic valve replacement (suSAVR) and surgical sutured aortic valve replacement (SAVR) in low-risk patients. In our study, we demonstrated no difference between suSAVR and stented SAVR in terms of 30-day complications, apart from marginally better hemodynamics, but with an increased rate of pacemaker implantation (PMI)and valve-related hospitalizations. 2 Lam K.Y. Reardon M.J. Yakubov S.J. et al. Surgical sutureless and sutured aortic valve replacement in low-risk patients. Ann Thorac Surg. 2022; 113: 616-622 Abstract Full Text Full Text PDF PubMed Scopus (5) Google Scholar Shooting Ourselves in the FootThe Annals of Thoracic SurgeryVol. 114Issue 6PreviewI read with great interest the article by Lam and colleagues1 comparing surgical aortic valve replacements using sutureless valves (suSAVRs) vs sutured valves. This ad hoc analysis of the Evolut Low Risk Trial confirmed what we have previously known about suSAVRs. Deployment is quick and hemodynamics are favorable, but there is a disadvantage of increased rates of permanent pacemaker implantation (PPMI).2 Importantly, this ad hoc analysis sheds a light on the Evolut Low Risk Trial itself, which may demonstrate some problems. Full-Text PDF